Clinical Trial Update: Safety and Preliminary Efficacy of TISA-818 Injection in Patients With Acute Respiratory Distress Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and preliminary efficacy of the TISA-818 Injection in patients with acute respiratory distress syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• TISA-818 Injection (TISA-818)

Snippet

Sponsor: EnliTISA (Shanghai) Pharmaceutical Co., Ltd. | Conditions: Acute Respiratory Distress Syndrome (ARDS) | Phase 2 | Status: COMPLETED